A practical approach to pediatric patients referred with an abnormal coagulation profile.

CONTEXT Workup for prolonged prothrombin time (PT) and activated partial thromboplastin time (PTT) is a frequent referral to a Hematology and Coagulation Laboratory. Although the workup should be performed in a timely and cost-effective manner, the complete laboratory assessment of the coagulation state has not been standardized. OBJECTIVE To determine which clinical and laboratory data are most predictive of a coagulopathy and to formulate the most efficient strategy to reach a diagnosis in patients referred for abnormal coagulation profiles. DESIGN Retrospective case review. Medical records of 251 patients referred for prolonged PT and/or PTT to our Hematology Service between June 1995 and December 2002 were reviewed. RESULTS The study included 135 males and 116 females with a mean age of 7.0 years. A personal history of bleeding was reported in 137 patients, and a family history of bleeding was reported in 116 patients. Fifty-one patients (20%) had a coagulopathy (ie, a bleeding risk). Factors predictive of a bleeding risk were a positive family history of bleeding (P < .001) and a positive personal history of bleeding (P = .001). Of 170 patients with findings of normal PT and PTT values on repeat testing, 14 were subsequently diagnosed with a coagulopathy. Two of these patients reported no positive personal or family history of bleeding. CONCLUSIONS Coagulopathy was identified in 20% of the children referred for abnormal PT and/or PTT. In the absence of a personal or family history of bleeding, a normal PT and/or PTT on repeat testing has a negative predictive value of more than 95%.

[1]  Laura J. Taylor Laboratory Management of the Bleeding Patient , 2003, American Society for Clinical Laboratory Science.

[2]  P. Visintainer,et al.  Clinical and Laboratory Features of 178 Children With Recurrent Epistaxis , 2002, Journal of pediatric hematology/oncology.

[3]  H. Austin,et al.  von Willebrand Disease and Other Inherited Bleeding Disorders in Women With Diagnosed Menorrhagia , 2001, Obstetrics and gynecology.

[4]  J. Teruya,et al.  A normal aPTT does not guarantee adequate coagulation factor levels. , 2001, Anesthesiology.

[5]  J. Petersen,et al.  Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[6]  J. Rutledge,et al.  The clinical impact of increased sensitivity PT and APTT coagulation assays. , 1999, American Journal of Clinical Pathology.

[7]  R. Hurwitz,et al.  414 Impact of managed care practices on the evaluation of children with suspected bleeding disorders , 1999 .

[8]  A. Kaider,et al.  Clinical significance of lupus anticoagulants in children. , 1999, The Journal of pediatrics.

[9]  R. Hannallah,et al.  Preoperative laboratory testing in children undergoing elective surgery: analysis of current practice. , 1997, Journal of clinical anesthesia.

[10]  M Plebani,et al.  Mistakes in a stat laboratory: types and frequency. , 1997, Clinical chemistry.

[11]  J. Lusher Screening and diagnosis of coagulation disorders. , 1996, American journal of obstetrics and gynecology.

[12]  C. Francis,et al.  Evaluation of mild bleeding disorders and easy bruising. , 1994, Blood reviews.

[13]  B. Chong,et al.  Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. , 1990, Australian and New Zealand journal of medicine.

[14]  J. Pearson,et al.  von Willebrand factor is an acute phase reactant in man. , 1989, Thrombosis research.

[15]  R. Russell,et al.  The prevalence of vitamin K deficiency in chronic gastrointestinal disorders. , 1985, The American journal of clinical nutrition.

[16]  C. Male Clinical signification of lupus anticoagulant in children , 1999 .

[17]  D. Ginsburg,et al.  Von Willebrand disease. , 2008, Pediatric clinics of North America.